Join
Live feed
·
INSIDERFilingvia Quantisnow
Chinook Therapeutics Inc. logo

SEC Form 4: King Andrew James converted options into 10,152 shares and sold $70,044 worth of shares (3,557 units at $19.69), increasing direct ownership by 112% to 12,492 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KDNY (Chinook Therapeutics Inc.) and more on Quantisnow.